on NOVACYT (EPA:ALNOV)
Novacyt Announces Relocation of Corporate Headquarters
Novacyt S.A., a global player in molecular diagnostics, has declared the relocation of its corporate headquarters. Effective immediately, the company's new address is 131 Boulevard Carnot, 78110 Le Vésinet, France. This move marks a strategic shift for the company, known for its extensive portfolio in genomic medicine technologies and services.
Novacyt is publicly listed on both Euronext Growth in Paris and the AIM in London. Despite its operational base in France, the company maintains a strong international presence with offices in the UK, Singapore, the USA, and Canada, serving over 65 countries globally.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NOVACYT news